Establishment and characterization of two cell lines (HEC-155, HEC-180) derived from uterine papillary serous adenocarcinoma

European Journal of Gynaecological Oncology

Volumn 25, Issue 4, 2004, Pages 423-427

  Iida, T ^a   Hamano, M ^b   Yoshida, N ^a   Yonamine, K ^a   Hayashi, K ^a   Kiguchi, K ^a   Ishizuka, B ^a   Nishimura, Y ^b   Arai, T ^b   Kawaguchi, M ^b   Hata, H ^c   Watanabe, J ^c   Kuramoto, H ^b,c  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell line; p53 mutation; Uterine papillary serous carcinoma (UPSC)

Indexed keywords

DNA; KI 67 ANTIGEN; PROTEIN P27; PROTEIN P53;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CASE REPORT; CELL GROWTH; CELL STRAIN HEC 155; CELL STRAIN HEC 180; CODON; CONTROLLED STUDY; CYSTADENOCARCINOMA; DNA SEQUENCE; ENDOMETRIUM CANCER; EXON; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MONOLAYER CULTURE; PROGNOSIS; PROTEIN DETERMINATION; UTERUS CANCER;

BIOPSY, NEEDLE; CELL DIVISION; CELL LINE, TUMOR; CYSTADENOCARCINOMA, PAPILLARY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; MIDDLE AGED; MUTATION; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEIN P53; UTERINE NEOPLASMS;

EID: 3242691710     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Jeffrey J.F., Krepart G.V., Lotocki R.J.: "Papillary serous adenocarcinoma of the endometrium". Obstet. Gynecol., 1986, 67, 670.
2. Ward B.G., Wright R.G., Free K.: "Papillary cacinomas of the endometrium". Gynecol. Oncol., 1990, 39, 347.
3. Gitsch G., Friedlander M.L., Wain G.V., Hacker N.F.: "Uterine papillary serous carcinoma". Cancer, 1995, 75 (9), 2239.
4. Kuramoto H., Hamano M., Imai M.: "HEC-1 cells". Human Cell., 2002, 15 (2), 81.
5. Seabright M.: "A rapid banding technique for human chromosomes". Lancet, 1971, 2, 971.
6. Orita M., Suzuki Y., Hayashi K.: "Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction". Genomics, 1989, 5, 874.
7. Goff B.A., Kato D., Schmidt R.A., Ek M., Ferry J.A., Muntz H.G., et al.: "Uterine papillary serous carcinoma: patterns of metastatic spread". Gynecol. Oncol., 1994, 54, 264.
8. Nordstrom B., Strang P., Lindgren A., Bergstrom R., Tribukait B.: "Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (UPSC) in relation to nuclear grade, DNA ploidy and p53 expression". Anticancer Res., 1996, 16, 899.
9. Zheng W., Cao P., Zheng M., Kramer E.E., Godwin T.A.: "p53 overexprssion and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes". Gynecol. Oncol., 1996, 61, 167.
10. Tashiro H., Isacson C., Levine R., Kurman R.J., Cho K.R., Hedrick L.: "p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis". Am. J. Pathol., 1997, 150 (1), 177.
11. Hockenbery D.M., Nunez G., Milliman C., Schreiber R.D., Korsmeyer S.J.: "Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death". Nature, 1990, 348, 334.
12. Ohkouchi T., Sakuragi N., Watari H., Nomura E., Todo Y., Yamada H., Fujimoto S.: "Prognostic significance of Bcl-2, p53 overexpression, and lymphnode metastasis in surgically staged endometrial carcinoma". Am. J. Obstet. Gynecol., 2002, 187 (2), 353.
13. Polyak K., Kato J.Y., Solomon M.J., Sherr C.J., Massague J., Roberts J.M., Koff A.: "p27Kip1, a cyclyn-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest". Gene. Dev., 1994, 8, 9.
14. Shiozawa T., Nikaido T., Nakayama K., Lu X., Fujii S.: "Involvement of cyclin-dependent kinase inhibitor p27Kip1 in growth inhibition of endometrium in the secretory phase and of hyperplastic endometrium treated with progesterone". Mol. Human Reprod., 1998, 4 (9), 899.
15. Bamberger A.M., Riethdorf L., Milde-Langosch K., Bamberger C.M., Thuneke I., Erdmann I. et al.: "Strongly reduced expression of the cell cycle inhibitor p27 in endometrial neoplasia". Virchows Arch., 1999, 434, 423.
16. Nycum L.R., Smith L.M., Farley J.H., Kost E.R., Method M.W., Birrer M.J.: "The role of p27 in endometrial carcinoma". Gynecol. Oncol., 2001, 81 (2), 242.
17. Watanabe J., Sato H., Kanai T., Kamata Y., Jobo T., Hata H. et al.: "Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus - correlation with proliferation and clinicopathological parameters". Br. J. Cancer, 2002, 81 (1), 81.
18. Schmitz M.J., Hendricks D.T., Farley J., Taylor R.R., Geradts J., Rose G.S., Birrer M.J.: "p27 and cyclin D1 abnormalities in uterine papillary serous carcinoma". Gynecol. Oncol., 2000, 77, 439.